EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Evaluation of Interventions for Cognitive Symptoms in Long COVID

David S Knopman, Deborah Koltai, Daniel T Laskowitz, Jacqueline Becker, Leigh Charvet, Juan Wisnivesky, Alex Federman, Adam Silverstein, Yuliya Lokhnygina, Giuseppina Pilloni, Michelle Haddad, Henry Mahncke und 37 weitere

JAMA Neurology · 01.01.2026 · 83 (1) · 49

DOI: 10.1001/jamaneurol.2025.4415 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Neurology, erschienen am 01.01.2026. Verfasst von David S Knopman und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: COVID-19, Cognitive Behavioral Therapy, Cognitive Dysfunction, Transcranial Direct Current Stimulation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NLM NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Treatment for cognitive dysfunction due to postacute sequelae of long COVID (ie, symptoms of fatigue, malaise, weakness, confusion that persist beyond 12 weeks after an initial COVID infection) remains a significant unmet need.

Objective

To test evidence-based rehabilitation strategies for improving cognitive symptoms in persons with long COVID. Design, Setting, and Participants This was a 5-arm, multicenter, randomized clinical trial of 3 remotely delivered interventions conducted between August 17, 2023, and June 10, 2024. The study took place at 22 trial sites and included the screening of individuals with cognitive long COVID.

Interventions

Participants were randomized to 1 of 5 arms: adaptive computerized cognitive training (BrainHQ [Posit Science]), cognitive-behavioral rehabilitation involving both group and individual counseling sessions (PASC-Cognitive Recovery [PASC-CoRE]) paired with BrainHQ, and transcranial direct current stimulation (tDCS) paired with BrainHQ. Two comparator arms were included as follows: unstructured computer puzzles and games (active comparator) and sham tDCS paired with BrainHQ. The interventions occurred 5 times per week over 10 weeks. Main Outcomes and Measures Cognitive and behavioral in-person assessments were performed at baseline, midintervention, at the end of intervention, and 3 months after the end of the intervention. The primary outcome measure was the modified Everyday Cognition Scale 2 (ECog2) completed at the end of the intervention compared to the baseline visit based on participant self-report looking back over the prior 7 days.

Results

A total of 378 individuals were screened, from which there were 328 participants (median [IQR] age, 48.0 [37.0-58.0] years; 241 female [73.5%]; race: 15 Asian [4.6%], 47 Black [14.3%], and 235 White [71.6%]; ethnicity: 52 Hispanic [15.9%]). None of the 3 active interventions demonstrated benefits on the modified ECog2 in the intention-to-treat population by the end of the intervention period. The adjusted differences in mean change were 0.0 (95% CI, −0.2 to 0.2) for BrainHQ vs active comparator, 0.1 (95% CI, −0.1 to 0.3) for PASC-CoRE + BrainHQ vs active comparator, 0.0 (95% CI, −0.2 to 0.2) for tDCS-active + BrainHQ vs tDCS-sham + BrainHQ, and 0.1 (95% CI, −0.1 to 0.3) for PASC-CoRE + BrainHQ vs BrainHQ alone. Secondary participant-reported outcomes and neuropsychological tests showed no differential benefits for any treatment arm. All 5 arms demonstrated some improvements over time on the modified ECog2 and on secondary outcomes. There were no serious adverse events attributable to the interventions. Conclusions and Relevance This phase 2 randomized clinical trial failed to demonstrate differential benefits for online cognitive training, a structured cognitive rehabilitation program, and tDCS for cognitive long COVID. Trial Registration ClinicalTrials.gov Identifier: NCT05965739 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cognitive Behavioral TherapyCognitive DysfunctionTranscranial Direct Current StimulationHumansFemaleMaleMiddle AgedAdultAgedTreatment Outcome

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic, Rochester, Minnesota.
  • Department of Neurology, Duke University School of Medicine, Durham, North Carolina.
  • Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Department of Neurology, Grossman School of Medicine, New York University, New York.
  • Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.

Förderung

  • NLM NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Knopman, D. S., Koltai, D., Laskowitz, D. T., Becker, J., Charvet, L., Wisnivesky, J., Federman, A., Silverstein, A., Lokhnygina, Y., Pilloni, G., Haddad, M., Mahncke, H., Van Vleet, T., Huang, R., Cox, W., Terry, D., Karwowski, J., McCray, N., Lin, J. J., …, & RECOVER-NEURO Clinical Trial Group (2026). Evaluation of Interventions for Cognitive Symptoms in Long COVID. JAMA Neurology, 83(1), 49. https://doi.org/10.1001/jamaneurol.2025.4415

Vancouver

Knopman DS, Koltai D, Laskowitz DT, Becker J, Charvet L, Wisnivesky J, et al. Evaluation of Interventions for Cognitive Symptoms in Long COVID. JAMA Neurology. 2026;83(1):49. doi:10.1001/jamaneurol.2025.4415

BibTeX
@article{Knopman2026,
  author = {Knopman, David S and Koltai, Deborah and Laskowitz, Daniel T and Becker, Jacqueline and Charvet, Leigh and Wisnivesky, Juan and Federman, Alex and Silverstein, Adam and Lokhnygina, Yuliya and Pilloni, Giuseppina and Haddad, Michelle and Mahncke, Henry and Van Vleet, Tom and Huang, Rong and Cox, Wendy and Terry, Diana and Karwowski, Jeannie and McCray, Netia and Lin, Jenny J and McComsey, Grace A and Singh, Upinder and Geng, Linda N and Chu, Helen Y and Reece, Rebecca and Moy, James and Arvanitakis, Zoe and Parthasarathy, Sairam and Patterson, Thomas F and Gupta, Aditi and Ostrosky-Zeichner, Luis and Parsonnet, Jeffrey and Kiriakopoulos, Elaine T and Fong, Tamara G and Mullington, Janet and Jolley, Sarah and Shah, Nirav S and Morimoto, Sarah Shizuko and Lee-Iannotti, Joyce K and Killgore, William D S and Dwyer, Brigid and Stringer, William and Isache, Carmen and Frontera, Jennifer A and Krishnan, Jerry A and O'Steen, Ashley and James, Melissa and Harper, Barrie L and Zimmerman, Kanecia O and RECOVER-NEURO Clinical Trial Group, RECOVER-NEURO Clinical Trial Group},
  title = {Evaluation of Interventions for Cognitive Symptoms in Long COVID},
  journal = {JAMA Neurology},
  year = {2026},
  volume = {83},
  number = {1},
  pages = {49},
  doi = {10.1001/jamaneurol.2025.4415}
}
Kostenlos starten →